drugset / Trial / NCT04150224
Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169
RandomizedSequentialOpen-labelBasic science
Summary
Open-label prospective non-comparative ascending dose randomized cohort study of single and multiple oral administration of PBTZ169 (capsules 80 mg) in healthy volunteers
Timeline
- Start
- 2018-07-03
- Primary completion
- 2018-11-23
- Completion
- 2019-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MACOZINONE | Small molecule | 640 mg | Oral |
| Subject | MACOZINONE | Small molecule | 960 mg | Oral |
| Subject | MACOZINONE | Small molecule | 1280 mg | Oral |
Indications
No indication recorded.